Scadden David
SEC CIK 1707715 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AGIO | AGIOS PHARMACEUTICALS, INC. | Dir | 20.4K | — | $98.2K | 17 | 2022-05-20 | 2026-06-18 |
Most active insiders at AGIO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Goff Brian | CEO, Dir | — | $1.69M |
| 2 | Gheuens Sarah | Chief Medical Off | — | $1.63M |
| 3 | Jones Cecilia | CFO | — | $468.5K |
| 4 | Milanova Tsveta | Chief Commercial Off | — | $353.3K |
| 5 | Burns James William | CLO | — | $344.4K |
| 6 | Washburn Theodore James Jr. | Principal Accounting Off | — | $216.6K |
| 7 | Viswanadhan Krishnan | Chief Corp Dev, Strategy | — | $185.0K |
| 8 | Scadden David | Dir | — | $25.0K |
| 9 | Owen Adams Catherine | Dir | — | — |
| 10 | Ballal Rahul D. | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 17:20 | 2026-06-18 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $0.00 | +2,816 | 20.4K | +16% | $0 |
| D | 2025-11-14 | 2025-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $18.09 | +200 | 17.8K | +1% | +$3,618 |
| D | 2025-11-14 | 2025-11-12 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | S - Sale+OE | $43.84 | -200 | 17.6K | -1% | -$8,768 |
| D | 2025-10-10 | 2025-10-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | S - Sale+OE | $41.00 | -200 | 17.6K | -1% | -$8,200 |
| D | 2025-10-10 | 2025-10-08 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $18.09 | +200 | 17.8K | +1% | +$3,618 |
| D | 2025-10-02 | 2025-09-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $18.09 | +200 | 17.8K | +1% | +$3,618 |
| D | 2025-10-02 | 2025-09-30 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | S - Sale+OE | $40.00 | -200 | 17.6K | -1% | -$8,000 |
| D | 2025-08-29 | 2025-08-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $18.09 | +200 | 17.8K | +1% | +$3,618 |
| D | 2025-08-29 | 2025-08-27 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | S - Sale+OE | $40.00 | -200 | 17.6K | -1% | -$8,000 |
| D | 2025-07-15 | 2025-07-10 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | S - Sale+OE | $40.00 | -1,400 | 17.6K | -7% | -$56.0K |
| D | 2025-07-15 | 2025-07-10 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $18.09 | +1,400 | 19.0K | +8% | +$25.3K |
| D | 2025-06-23 | 2025-06-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $0.00 | +2,120 | 17.6K | +14% | $0 |
| D | 2024-12-13 | 2024-12-11 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | S - Sale+OE | $46.28 | -200 | 15.5K | -1% | -$9,256 |
| D | 2024-12-13 | 2024-12-11 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $18.09 | +200 | 15.7K | +1% | +$3,618 |
| D | 2024-06-17 | 2024-06-13 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $0.00 | +3,388 | 15.5K | +28% | $0 |
| D | 2023-06-23 | 2023-06-21 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $0.00 | +4,975 | 12.1K | +70% | $0 |
| D | 2022-05-24 | 2022-05-20 | AGIO | AGIOS PHARMACEUTICALS, INC. | Scadden David | Dir | M - OptEx | $0.00 | +1,585 | 7,120 | +29% | $0 |
Purchase Sale Sale after option exercise All abbreviations